Interlaboratory variation in antiphospholipid antibody testing

Alan M. Peaceman*, Richard K. Silver, Scott N. MacGregor, Michael L. Socol

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

91 Scopus citations

Abstract

OBJECTIVE: Because of the widespread use of antiphospholipid antibody testing in the evaluation of patients with recurrent pregnancy loss, we evaluated the consistency of results among laboratories testing for anticardiolipin antibody and the lupus anticoagulant. STUDY DESIGN: A questionnaire regarding methods used and samples of blood from 20 patients were sent to five university-based and five commercial facilities for antiphospholipid antibody testing. RESULTS: The responses of the participating laboratories to the questionnaires revealed significant differences in methods, standardization, and units of reporting. For anticardiolipin antibody, the number of specimens found to be positive for any isotype (immunoglobulin G, M, or A) varied considerably among laboratories, with a range of 5 to 13. All laboratories were in agreement (i.e., at least one isotype was present or all were absent) for only 5 of 20 specimens (25%). In contrast, lupus anticoagulant results were more reproducible, although one facility reported results markedly discordant from the other four laboratories. CONCLUSION: These observations suggest that significant interlaboratory variation exists in antiphospholipid antibody, and particularly anticardiolipin antibody, testing and might lead to unnecessary therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)1780-1787
Number of pages8
JournalAmerican journal of obstetrics and gynecology
Volume166
Issue number6 PART 1
DOIs
StatePublished - Jun 1992

Keywords

  • Antiphospholipid antibodies
  • anticardiolipin antibody
  • lupus anticoagulant
  • recurrent pregnancy loss

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Interlaboratory variation in antiphospholipid antibody testing'. Together they form a unique fingerprint.

Cite this